Phase 1 Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

Phase: PHASE1 | Sponsor: Deepak C. D'Souza | Compound: DMT

Status

recruiting

Institution

Deepak C. D'Souza

Start date

2025-03-14

End date

2027-12-01

Registry ID

NCT06671977

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.